• SK Discovery subsidiary SK Plasma signed a KRW 62.71 billion blood products supply contract with Arvatera ilac Sanayi ve Ticaret.
• The contract covers supplies to Türkiye from Oct. 29, 2026, through Sept. 30, 2027.
• The order represents 28.64% of SK Plasma’s 2025 consolidated revenue.
• Payment is due within 60 or 120 days of shipment, with no upfront payment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SK Discovery Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261030801006), on October 30, 2026, and is solely responsible for the information contained therein.